arrow
R

Robert C. Bourge

University of Alabama System
H指数:69
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aggressive Afterload Lowering to Improve the Right Ventricle A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
2022-04-0131
OAAI
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure One-Year Outcomes From the CardioMEMS Post-Approval Study

来自CardioMEMS批准后研究的肺动脉压力引导的门诊心力衰竭治疗期间心力衰竭和全因住院率较低

2020-08-01139
OAAI
Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure
CHEST
IF8.6
2017-12-0114
PREAI
Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?

急性心力衰竭入院的前24小时收缩压降低: 朋友还是敌人?

2017-09-0419
OAAI
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failuredoes it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS)

心力衰竭患者入院后不久肌钙蛋白和利钠肽的测量是否增加了有用的预后信息?在急性心力衰竭研究 (VERITAS) 中使用Tezosentan抑制内皮素受体的价值分析

2017-03-1026
OAAI
Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS

急性心力衰竭患者住院时间的预测因素及其与预后的关系: 来自VERITAS的结果

2016-10-0130
OAAI
Expert Consensus on the Prescribing Practice and Management of Adverse Events Associated With the Treatment of Patients Taking Macitentan for PAH: A Delphi Consensus Study
CHEST
IF8.6
2016-10-010
OAAI
Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study

老年急性心力衰竭: VERITAS研究中临床特征,结果和预后因素的差异

2015-03-0162
PREAI
Heart Failure and Respiratory Hospitalizations Are Reduced in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease With the Use of an Implantable Pulmonary Artery Pressure Monitoring Device

使用植入式肺动脉压力监测装置可减少心力衰竭和慢性阻塞性肺疾病患者的心力衰竭和呼吸系统住院

2015-03-0146
OAAI